Description: 

ATS (Anthrax Vaccine) is an inactivated vaccine used to protect against anthrax infection.

Doage Form: 

Injection (suspension)

Strength: 

Typically 0.5mL or 1mL per dose

Active Ingredients:

1. Inactivated Bacillus anthracis sterile filtrate

Indications: 

Prevention of:

1. Anthrax infection
2. Cutaneous anthrax
3. Inhalational anthrax

Contraindications:

1. Hypersensitivity to anthrax vaccine or components
2. Severe allergic reactions to previous doses
3. Pregnancy (unless benefits outweigh risks)
4. Breastfeeding (unless benefits outweigh risks)

Side Effects:

1. Injection site reactions (pain, redness, swelling)
2. Fatigue
3. Headache
4. Muscle pain
5. Allergic reactions

Precautions:

1. Monitor for severe allergic reactions
2. Use with caution in immunocompromised individuals
3. Consult a healthcare professional

Prescription/OTC:

 Prescription-only

Manufacturer Information:

Vins Bioproducts ltd

Country of Origin:

India

Category of Drug:

 Vaccine (inactivated)

Notes:

– Administered by healthcare professional.

– Typical dosage schedule: 0.5mL IM at 0, 1, and 6 months, with annual boosters.

– Monitor for injection site reactions and systemic side effects.

Important Safety Information:

– Severe allergic reactions can occur; monitor patients closely.

– Guillain-Barré Syndrome (GBS) has been reported; monitor for neurological symptoms.

Additional Information:

– Storage: Store refrigerated (2-8°C/36-46°F)

– Shelf Life: Typically 2-3 years from manufacture date

– Approval: FDA-approved (2002)